Chimeric Therapeutics Limited (ASX:CHM)
Australia · Delayed Price · Currency is AUD 0.1350
-0.0100 (-6.90%)
May 8, 2026, 4:10 PM AEST
Chimeric Therapeutics Market Cap
Chimeric Therapeutics has a market cap or net worth of 7 million as of May 8, 2026. Its market cap has increased by 7.95% in one year.
Market Cap
7.00M
Enterprise Value
4.49M
Revenue
9.75M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.14
Market Cap Chart
Since January 18, 2021, Chimeric Therapeutics's market cap has decreased from 97.50M to 7.00M, a decrease of -92.82%. That is a compound annual growth rate of -39.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 7.00M | -14.87% |
| Dec 31, 2025 | 8.22M | -25.46% |
| Dec 31, 2024 | 11.02M | -56.60% |
| Dec 29, 2023 | 25.40M | -27.35% |
| Dec 30, 2022 | 34.97M | -59.93% |
| Dec 31, 2021 | 87.26M | -10.51% |
| Jan 18, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AdAlta | 12.75M |
| Cambium Bio | 12.03M |
| Bio-Gene Technology | 10.68M |
| Invex Therapeutics | 9.77M |
| Immuron | 8.49M |
| Biotron | 8.11M |
| Tissue Repair | 7.26M |
| Vectus Biosystems | 6.68M |